腹部全体痛シリーズ(Generalized Abdominal Pain)8 RESIDENT COURSE 解答 【症例 GR 39】

Ogilvie症候群.Ogilvie’s syndrome






図1の腹部単純写真でガスで拡張した腸管▲はcoffee bean signを呈し,S状結腸捻転の可能性がある.図13の直腸1から逆行性に追跡すると図2の12となり,図2の下行結腸Aは図7でUターンして図6のGからS状結腸となり頭側へ上行する.すべての結腸が液状便とガスで拡張し,捻転を認めず,Ogilvie症候群(急性結腸偽性閉塞症:acute pseudo-obstruction)である.ネラトンチューブを肛門より挿入しガスと液状便1200mlを吸引し改善した.







文献考察:Ogilvie症候群
Curr Treat Options Gastroenterol. 2000 Aug;3(4):273-286.
Acute Intestinal Pseudo-obstruction.
Quigley EM.

Acute pseudo-obstruction may manifest clinically in one of three forms--acute gastroparesis, ileus, and acute colonic pseudo-obstruction (Ogilvie's syndrome). Though formerly associated primarily with the postoperative state, these entities are increasingly recognized in association with a wide variety of major medical problems. There are few controlled studies to guide the clinician in the management of these disorders. Treatment remains largely empirical, and time-honored, based primarily on "bowel rest," nasogastric decompression, and supportive care. While a wide variety of pharmacologic approaches have been advocated, few have been subjected to, or survived, the rigors of a properly controlled trial. Neostigmine is a notable exception, and has been shown to be effective in Ogilvie's syndrome. Perforation is a significant threat in megacolon; colonoscopic, or surgical decompression may, therefore, be indicated. Both are associated with significant risks in this context, but may prevent progression to perforation with its attendant mortality. New approaches seek to exploit current concepts in the pathophysiology of ileus and megacolon but have not, as yet, achieved efficacy in human studies.    PMID: 11096588
追記:大腸穿孔の頻度は3%.盲腸は直径9cmから異常であるが,12cmを超えると穿孔のリスクは高い.盲腸の拡張が6日以上経過すると穿孔の危険が増す.Neostigmine2mg静注が効果的なことがある.
  【参照症例】   1. 下腹部痛シリーズ(Lower Abdominal Pain) 17 【症例 LR 85】

 【 ←前の問題 】   【 次の問題→ 】  【 このシリーズの問題一覧に戻る 】 【 演習問題一覧に戻る 】